0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Plasma Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-7W8882
Home | Market Reports | Health| Pharmacy
China Blood Plasma Market Report Forecast 2021 2027
BUY CHAPTERS

Global Blood Plasma Market Research Report 2025

Code: QYRE-Auto-7W8882
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blood Plasma Market Size

The global market for Blood Plasma was valued at US$ 426 million in the year 2024 and is projected to reach a revised size of US$ 499 million by 2031, growing at a CAGR of 2.3% during the forecast period.

Blood Plasma Market

Blood Plasma Market

Colloids (blood plasma) are the substances of expanding the circulating blood volume, which mainly contain albumin type, gelatin type, dextran type and hydroxyethyl starch type.
Colloids (Blood Plasma) can be applied for extensive burns, massive blood or plasma loss and hypovolemic shock. In this report, we calculate colloids (blood plasma) preparations, which is produced by albumin, gelatin, dextran and hydroxyethyl starch.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blood Plasma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Plasma.
The Blood Plasma market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Plasma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Plasma manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Blood Plasma Market Report

Report Metric Details
Report Name Blood Plasma Market
Accounted market size in year US$ 426 million
Forecasted market size in 2031 US$ 499 million
CAGR 2.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Immunoglobulin
  • Albumin
  • Protease Inhibitors
  • Coagulation Factor Concentrates
  • Others
Segment by Application
  • Hospitals and Clinics
  • Research Laboratories
  • Academic Institutions
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas, TCS Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Blood Plasma manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Blood Plasma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Blood Plasma Market growing?

Ans: The Blood Plasma Market witnessing a CAGR of 2.3% during the forecast period 2025-2031.

What is the Blood Plasma Market size in 2031?

Ans: The Blood Plasma Market size in 2031 will be US$ 499 million.

Who are the main players in the Blood Plasma Market report?

Ans: The main players in the Blood Plasma Market are Baxter International, CSL, Grifols, Octapharma, ADMA Biologics, Cerus Corp, Sanquin, Shanghai Raas, TCS Biosciences

What are the Application segmentation covered in the Blood Plasma Market report?

Ans: The Applications covered in the Blood Plasma Market report are Hospitals and Clinics, Research Laboratories, Academic Institutions

What are the Type segmentation covered in the Blood Plasma Market report?

Ans: The Types covered in the Blood Plasma Market report are Immunoglobulin, Albumin, Protease Inhibitors, Coagulation Factor Concentrates, Others

1 Blood Plasma Market Overview
1.1 Product Definition
1.2 Blood Plasma by Type
1.2.1 Global Blood Plasma Market Value Comparison by Type (2024 VS 2031)
1.2.2 Immunoglobulin
1.2.3 Albumin
1.2.4 Protease Inhibitors
1.2.5 Coagulation Factor Concentrates
1.2.6 Others
1.3 Blood Plasma by Application
1.3.1 Global Blood Plasma Market Value by Application (2024 VS 2031)
1.3.2 Hospitals and Clinics
1.3.3 Research Laboratories
1.3.4 Academic Institutions
1.4 Global Blood Plasma Market Size Estimates and Forecasts
1.4.1 Global Blood Plasma Revenue 2020-2031
1.4.2 Global Blood Plasma Sales 2020-2031
1.4.3 Global Blood Plasma Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Blood Plasma Market Competition by Manufacturers
2.1 Global Blood Plasma Sales Market Share by Manufacturers (2020-2025)
2.2 Global Blood Plasma Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Blood Plasma Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Blood Plasma, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Blood Plasma, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blood Plasma, Product Type & Application
2.7 Global Key Manufacturers of Blood Plasma, Date of Enter into This Industry
2.8 Global Blood Plasma Market Competitive Situation and Trends
2.8.1 Global Blood Plasma Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Blood Plasma Players Market Share by Revenue
2.8.3 Global Blood Plasma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Blood Plasma Market Scenario by Region
3.1 Global Blood Plasma Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Blood Plasma Sales by Region: 2020-2031
3.2.1 Global Blood Plasma Sales by Region: 2020-2025
3.2.2 Global Blood Plasma Sales by Region: 2026-2031
3.3 Global Blood Plasma Revenue by Region: 2020-2031
3.3.1 Global Blood Plasma Revenue by Region: 2020-2025
3.3.2 Global Blood Plasma Revenue by Region: 2026-2031
3.4 North America Blood Plasma Market Facts & Figures by Country
3.4.1 North America Blood Plasma Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Blood Plasma Sales by Country (2020-2031)
3.4.3 North America Blood Plasma Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Blood Plasma Market Facts & Figures by Country
3.5.1 Europe Blood Plasma Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Blood Plasma Sales by Country (2020-2031)
3.5.3 Europe Blood Plasma Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Plasma Market Facts & Figures by Region
3.6.1 Asia Pacific Blood Plasma Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Blood Plasma Sales by Region (2020-2031)
3.6.3 Asia Pacific Blood Plasma Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Blood Plasma Market Facts & Figures by Country
3.7.1 Latin America Blood Plasma Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Blood Plasma Sales by Country (2020-2031)
3.7.3 Latin America Blood Plasma Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Plasma Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Plasma Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Blood Plasma Sales by Country (2020-2031)
3.8.3 Middle East and Africa Blood Plasma Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Blood Plasma Sales by Type (2020-2031)
4.1.1 Global Blood Plasma Sales by Type (2020-2025)
4.1.2 Global Blood Plasma Sales by Type (2026-2031)
4.1.3 Global Blood Plasma Sales Market Share by Type (2020-2031)
4.2 Global Blood Plasma Revenue by Type (2020-2031)
4.2.1 Global Blood Plasma Revenue by Type (2020-2025)
4.2.2 Global Blood Plasma Revenue by Type (2026-2031)
4.2.3 Global Blood Plasma Revenue Market Share by Type (2020-2031)
4.3 Global Blood Plasma Price by Type (2020-2031)
5 Segment by Application
5.1 Global Blood Plasma Sales by Application (2020-2031)
5.1.1 Global Blood Plasma Sales by Application (2020-2025)
5.1.2 Global Blood Plasma Sales by Application (2026-2031)
5.1.3 Global Blood Plasma Sales Market Share by Application (2020-2031)
5.2 Global Blood Plasma Revenue by Application (2020-2031)
5.2.1 Global Blood Plasma Revenue by Application (2020-2025)
5.2.2 Global Blood Plasma Revenue by Application (2026-2031)
5.2.3 Global Blood Plasma Revenue Market Share by Application (2020-2031)
5.3 Global Blood Plasma Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Baxter International
6.1.1 Baxter International Company Information
6.1.2 Baxter International Description and Business Overview
6.1.3 Baxter International Blood Plasma Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Baxter International Blood Plasma Product Portfolio
6.1.5 Baxter International Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Blood Plasma Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Blood Plasma Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Blood Plasma Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Grifols Blood Plasma Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Company Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Blood Plasma Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Octapharma Blood Plasma Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 ADMA Biologics
6.5.1 ADMA Biologics Company Information
6.5.2 ADMA Biologics Description and Business Overview
6.5.3 ADMA Biologics Blood Plasma Sales, Revenue and Gross Margin (2020-2025)
6.5.4 ADMA Biologics Blood Plasma Product Portfolio
6.5.5 ADMA Biologics Recent Developments/Updates
6.6 Cerus Corp
6.6.1 Cerus Corp Company Information
6.6.2 Cerus Corp Description and Business Overview
6.6.3 Cerus Corp Blood Plasma Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Cerus Corp Blood Plasma Product Portfolio
6.6.5 Cerus Corp Recent Developments/Updates
6.7 Sanquin
6.7.1 Sanquin Company Information
6.7.2 Sanquin Description and Business Overview
6.7.3 Sanquin Blood Plasma Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanquin Blood Plasma Product Portfolio
6.7.5 Sanquin Recent Developments/Updates
6.8 Shanghai Raas
6.8.1 Shanghai Raas Company Information
6.8.2 Shanghai Raas Description and Business Overview
6.8.3 Shanghai Raas Blood Plasma Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shanghai Raas Blood Plasma Product Portfolio
6.8.5 Shanghai Raas Recent Developments/Updates
6.9 TCS Biosciences
6.9.1 TCS Biosciences Company Information
6.9.2 TCS Biosciences Description and Business Overview
6.9.3 TCS Biosciences Blood Plasma Sales, Revenue and Gross Margin (2020-2025)
6.9.4 TCS Biosciences Blood Plasma Product Portfolio
6.9.5 TCS Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Plasma Industry Chain Analysis
7.2 Blood Plasma Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Plasma Production Mode & Process Analysis
7.4 Blood Plasma Sales and Marketing
7.4.1 Blood Plasma Sales Channels
7.4.2 Blood Plasma Distributors
7.5 Blood Plasma Customer Analysis
8 Blood Plasma Market Dynamics
8.1 Blood Plasma Industry Trends
8.2 Blood Plasma Market Drivers
8.3 Blood Plasma Market Challenges
8.4 Blood Plasma Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Blood Plasma Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Blood Plasma Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Blood Plasma Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Blood Plasma Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Blood Plasma Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Blood Plasma Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Blood Plasma Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Blood Plasma Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Blood Plasma, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Blood Plasma, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Blood Plasma, Product Type & Application
 Table 12. Global Key Manufacturers of Blood Plasma, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Blood Plasma by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Plasma as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Blood Plasma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Blood Plasma Sales by Region (2020-2025) & (K Units)
 Table 18. Global Blood Plasma Sales Market Share by Region (2020-2025)
 Table 19. Global Blood Plasma Sales by Region (2026-2031) & (K Units)
 Table 20. Global Blood Plasma Sales Market Share by Region (2026-2031)
 Table 21. Global Blood Plasma Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Blood Plasma Revenue Market Share by Region (2020-2025)
 Table 23. Global Blood Plasma Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Blood Plasma Revenue Market Share by Region (2026-2031)
 Table 25. North America Blood Plasma Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Blood Plasma Sales by Country (2020-2025) & (K Units)
 Table 27. North America Blood Plasma Sales by Country (2026-2031) & (K Units)
 Table 28. North America Blood Plasma Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Blood Plasma Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Blood Plasma Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Blood Plasma Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Blood Plasma Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Blood Plasma Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Blood Plasma Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Blood Plasma Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Blood Plasma Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Blood Plasma Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Blood Plasma Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Blood Plasma Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Blood Plasma Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Blood Plasma Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Blood Plasma Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Blood Plasma Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Blood Plasma Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Blood Plasma Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Blood Plasma Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Blood Plasma Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Blood Plasma Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Blood Plasma Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Blood Plasma Sales (K Units) by Type (2020-2025)
 Table 51. Global Blood Plasma Sales (K Units) by Type (2026-2031)
 Table 52. Global Blood Plasma Sales Market Share by Type (2020-2025)
 Table 53. Global Blood Plasma Sales Market Share by Type (2026-2031)
 Table 54. Global Blood Plasma Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Blood Plasma Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Blood Plasma Revenue Market Share by Type (2020-2025)
 Table 57. Global Blood Plasma Revenue Market Share by Type (2026-2031)
 Table 58. Global Blood Plasma Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Blood Plasma Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Blood Plasma Sales (K Units) by Application (2020-2025)
 Table 61. Global Blood Plasma Sales (K Units) by Application (2026-2031)
 Table 62. Global Blood Plasma Sales Market Share by Application (2020-2025)
 Table 63. Global Blood Plasma Sales Market Share by Application (2026-2031)
 Table 64. Global Blood Plasma Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Blood Plasma Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Blood Plasma Revenue Market Share by Application (2020-2025)
 Table 67. Global Blood Plasma Revenue Market Share by Application (2026-2031)
 Table 68. Global Blood Plasma Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Blood Plasma Price (USD/Unit) by Application (2026-2031)
 Table 70. Baxter International Company Information
 Table 71. Baxter International Description and Business Overview
 Table 72. Baxter International Blood Plasma Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Baxter International Blood Plasma Product
 Table 74. Baxter International Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Blood Plasma Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. CSL Blood Plasma Product
 Table 79. CSL Recent Developments/Updates
 Table 80. Grifols Company Information
 Table 81. Grifols Description and Business Overview
 Table 82. Grifols Blood Plasma Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Grifols Blood Plasma Product
 Table 84. Grifols Recent Developments/Updates
 Table 85. Octapharma Company Information
 Table 86. Octapharma Description and Business Overview
 Table 87. Octapharma Blood Plasma Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Octapharma Blood Plasma Product
 Table 89. Octapharma Recent Developments/Updates
 Table 90. ADMA Biologics Company Information
 Table 91. ADMA Biologics Description and Business Overview
 Table 92. ADMA Biologics Blood Plasma Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. ADMA Biologics Blood Plasma Product
 Table 94. ADMA Biologics Recent Developments/Updates
 Table 95. Cerus Corp Company Information
 Table 96. Cerus Corp Description and Business Overview
 Table 97. Cerus Corp Blood Plasma Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Cerus Corp Blood Plasma Product
 Table 99. Cerus Corp Recent Developments/Updates
 Table 100. Sanquin Company Information
 Table 101. Sanquin Description and Business Overview
 Table 102. Sanquin Blood Plasma Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Sanquin Blood Plasma Product
 Table 104. Sanquin Recent Developments/Updates
 Table 105. Shanghai Raas Company Information
 Table 106. Shanghai Raas Description and Business Overview
 Table 107. Shanghai Raas Blood Plasma Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Shanghai Raas Blood Plasma Product
 Table 109. Shanghai Raas Recent Developments/Updates
 Table 110. TCS Biosciences Company Information
 Table 111. TCS Biosciences Description and Business Overview
 Table 112. TCS Biosciences Blood Plasma Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. TCS Biosciences Blood Plasma Product
 Table 114. TCS Biosciences Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Blood Plasma Distributors List
 Table 118. Blood Plasma Customers List
 Table 119. Blood Plasma Market Trends
 Table 120. Blood Plasma Market Drivers
 Table 121. Blood Plasma Market Challenges
 Table 122. Blood Plasma Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Blood Plasma
 Figure 2. Global Blood Plasma Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Blood Plasma Market Share by Type: 2024 & 2031
 Figure 4. Immunoglobulin Product Picture
 Figure 5. Albumin Product Picture
 Figure 6. Protease Inhibitors Product Picture
 Figure 7. Coagulation Factor Concentrates Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Blood Plasma Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Blood Plasma Market Share by Application: 2024 & 2031
 Figure 11. Hospitals and Clinics
 Figure 12. Research Laboratories
 Figure 13. Academic Institutions
 Figure 14. Global Blood Plasma Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Blood Plasma Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Blood Plasma Sales (2020-2031) & (K Units)
 Figure 17. Global Blood Plasma Average Price (USD/Unit) & (2020-2031)
 Figure 18. Blood Plasma Report Years Considered
 Figure 19. Blood Plasma Sales Share by Manufacturers in 2024
 Figure 20. Global Blood Plasma Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Blood Plasma Players: Market Share by Revenue in Blood Plasma in 2024
 Figure 22. Blood Plasma Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Blood Plasma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Blood Plasma Sales Market Share by Country (2020-2031)
 Figure 25. North America Blood Plasma Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Blood Plasma Sales Market Share by Country (2020-2031)
 Figure 29. Europe Blood Plasma Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Blood Plasma Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Blood Plasma Revenue Market Share by Region (2020-2031)
 Figure 37. China Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Blood Plasma Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Blood Plasma Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Blood Plasma Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Blood Plasma Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Blood Plasma Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Blood Plasma by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Blood Plasma by Type (2020-2031)
 Figure 59. Global Blood Plasma Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Blood Plasma by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Blood Plasma by Application (2020-2031)
 Figure 62. Global Blood Plasma Price (USD/Unit) by Application (2020-2031)
 Figure 63. Blood Plasma Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart